Turkish Journal of Anaesthesiology & Reanimation

Sugammadex in a Patient with Brugada Syndrome


Çukurova Üniversitesi Tıp Fakültesi, Anesteziyoloji ve Reanimasyon Anabilim Dalı, Adana, Türkiye

Turk J Anaesthesiol Reanim 2016; 44: 99-101
DOI: 10.5152/TJAR.2016.60973
Read: 414 Downloads: 161 Published: 26 September 2019

Brugada Syndrome was first described in1992 by Pedro Brugada as a genetic syndrome that is characterized by ventricular arrhythmias that may result in sudden cardiac arrest. In particular, a right bundle branch block and ST segment elevation in the right precordial leads are observed. Many perioperative pharmalogical and physiological factors can trigger malignant arrhythmias. Although it is a rare condition, the anaesthestic management of Brugada syndrome is important because of the potentially fatal complications. Many anaesthetics have been administered during the operation of patients with Brugada Syndrome. The use of sugammadex instead of the anaesthetic management of patients with Brugada syndrome is discussed in this study.

EISSN 2667-6370